Pulse Biosciences, Inc. PLSE Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.
The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulse Biosciences, Inc.'s stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulse Biosciences, Inc.'s stock issuance proceeds?
- Pulse Biosciences, Inc. (PLSE) reported stock issuance proceeds of $1.67M in Q1 2026.
- How has Pulse Biosciences, Inc.'s stock issuance proceeds changed year-over-year?
- Pulse Biosciences, Inc.'s stock issuance proceeds increased by 340.5% year-over-year, from $380K to $1.67M.
- What is the long-term trend for Pulse Biosciences, Inc.'s stock issuance proceeds?
- Over 3 years (2021 to 2025), Pulse Biosciences, Inc.'s stock issuance proceeds has grown at a -64.7% compound annual growth rate (CAGR), from $56.7M to $2.49M.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.